Cogwear Featured as a Startup to Watch in 2025
Cogwear was listed as one of PHL Inno’s Startups to Watch.
Interius Ranks in Top Ten of Capital Raises by Philadelphia Startups in 2024
Interius was recognized in the Philadelphia Business Journal’s “PHL Inno 2024 in Review” as one of the top Philadelphia-area startups raising capital last year.
Gemma Biotherapeutics and Franklin Biolabs Established to Focus on Rare Diseases
Gemma Bio raised $34 million in a seed round led by Double Point Ventures, Bioluminescence Ventures and Earlybird Venture Capital.
Stentix Awarded 2025 Y-Prize
Stentix won the 2025 Y-Prize competition after presenting their business plan for a bile duct stent that can be adjusted noninvasively to help patients maintain bile flow without further surgical inte
Michael Kahana Featured in NY Post for Memory Research
Michael Kahana was recently featured in the New York Post for his cutting-edge research in memory recall.
Penn Engineering’s Shu Yang to Co-Design Artificial Reef Structures that Help Harness Wave Energy
Dr. Yang’s focus is developing low-cost and recycled carbonated materials that are safe for, and tolerant of, the marine environment.
Jay Z’s Shawn Carter Foundation Collaborates with the Wharton School to Launch ‘Champions for Financial Legacy’ Program for HBCUs
This partnership focuses on transforming Dr. Weigelt's community program, "Bridges to Wealth," into a broader initiative called "Champions for Financial Legacy."
Mitchell Lab Discovers Siloxane-Enhanced Nanoparticles and Refines LNPs to Advance mRNA Medicine
A group of researchers at Penn Engineering led by Michael Mitchell, PhD, Associate Professor in Bioengineering, have developed a method to direct lipid nanoparticles (LNPs) to target specific tissues.
Franklin Biolabs Names its First CEO
Franklin Biolabs, a Penn spinout founded by James Wilson, MD, PhD, Rose H. Weiss Professor in Penn Medicine, has named Vatsala Naageshwaran as its first chief executive officer.
Ocuphire Pharma Announces Acquisition of Opus Genetics, a Penn startup based on technology developed by Dr. Jean Bennett and colleagues
The merger between Opus and Ocuphire creates a transformative biotech company, renamed Opus Genetics, Inc, which is committed to the development of gene therapies for the treatment of IRDs.